Table 1 The demographic data of the uveal melanoma patients

Age in years (mean ± SD, range)

52 ± 15

15–84

Tumor Shape (N, %)

Mushroom

71

43.30%

Patient's gender (N, %)

Female

78

47.60%

Dome

78

47.60%

Male

86

52.40%

Flat

11

6.70%

Diffuse

4

2.40%

Vision (logMar, mean ± SD, range)

1.13 ± 1.2

0–5

Lesion Color (N, %)

Melanotic

156

95.12%

IOP (mean ± SD, range)

14.72 ± 2.8

7–33

Amelanotic

7

4.26%

Mix

1

0.60%

Weight (Kg) of patient (mean ± SD, range)

71 ± 13

38–107

Height (cm) of patient (mean ± SD, range)

163 ± 13

50–192

Pigment dispersion (N, %)

Yes

47

28.70%

Body Mass Index (mean ± SD, range)

26 ± 4

17–43

No

117

71.30%

Iris Nevus (N, %)

Yes

3

1.80%

Smoking (N, %)

Yes

52

31.70%

No

157

95.70%

No

112

68.30%

Alcohol (N, %)

Yes

24

14.60%

Basal diameter (mean ± SD, range)

14.20 ± 3.62

1.50–22.5

No

140

85.40%

Thickness of lesion (mean ± SD, range)

8.29 ± 3.29

1.14–16.43

Distance to fovea (mm, mean ± SD, range)

3 ± 4

0–16

Duration of symptoms (Weeks, Mean ± SD, range)

103.41 ± 103.76

85–1395

Distance to optic disc (mm, mean ± SD, range)

3 ± 4

0–17

Orange pigment (N, %)

Yes

94

57.30%

Symptoms (N, %)

Redness

4

2.40%

No

70

42.70%

Pain

15

9.10%

Drusen (N, %)

Yes

1

0.60%

Flashing

16

9.80%

No

87

54.00%

Blurred Vision

120

73.20%

N/S

73

45.30%

Floater

7

4.30%

Halo (N, %)

Yes

1

0.60%

N/S

2

1.20%

No

88

53.70%

N/S

75

45.70%

Type of disease (N, %)

CH Melanoma

145

88.40%

Ciliary body Melanoma

17

10.40%

Subretinal fluid (N, %)

Yes

138

84.10%

Iris Melanoma

2

1.20%

No

155

96.20%

Extraocular extension

Yes

4

2.50%

Laterality (N, %)

Left

76

46.30%

No

160

97.5%

Right

88

53.70%

Treatment (N, %)

Brachytherapy I-125

13

7.90%

Quadrant Location (N, %)

Superior

22

13.40%

Brachytherapy¹⁰⁶Ru

98

57.5%

Nasal

22

13.40%

TTT

4

2.40%

Inferior

29

17.70%

Enucleated

46

28.00%

Temporal

25

15.20%

Peripapillary

11

6.70%

PDT

3

1.80%

Inf-Temporal

8

4.90%

Brachy/enucleation/refused

4

2.40%

Inf-Nasal

14

8.50%

Sup-Temporal

11

6.70%

Sup-Nasal

11

6.70%